PMCB
PharmaCyte Biotech Inc
NASDAQ: PMCB · HEALTHCARE · BIOTECHNOLOGY
$0.75
-1.32% today
Updated 2026-04-29
Market cap
$8.05M
P/E ratio
—
P/S ratio
12,904.41x
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
PharmaCyte Biotech Inc (PMCB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.14M | $4.41M | $7.62M | $6.84M | $1.20M | $1.24M | $2.09M | $2.88M | $9.32M | $7.95M | $7.16M | $8.67M | $6.41M | $5.78M | $6.17M | $7.40M | $90.62M | $73.28M | $59.90M | $55.17M |
| Cash & equivalents | $1.07M | $1.11M | $1.51M | $603727.00 | $716.00 | $57201.00 | $15723.00 | $199303.00 | $3.62M | $2.70M | $1.92M | $3.46M | $1.06M | $515253.00 | $894861.00 | $2.20M | $85.40M | $68.04M | $50.18M | $15.17M |
| Current assets | $3.13M | $3.43M | $3.74M | $1.18M | $13679.00 | $104747.00 | $1.06M | $1.85M | $4.19M | $2.82M | $2.03M | $3.54M | $1.28M | $653404.00 | $1.04M | $2.28M | $85.49M | $68.15M | $50.44M | $22.38M |
| Total liabilities | $723893.00 | $118806.00 | $180558.00 | $2.85M | $3.15M | $3.97M | $4.37M | $3.80M | $373666.00 | $2.01M | $637639.00 | $580248.00 | $644168.00 | $742851.00 | $1.08M | $724778.00 | $704370.00 | $586581.00 | $20.39M | $3.28M |
| Current liabilities | $106213.00 | $118806.00 | $180558.00 | $918796.00 | $3.05M | $3.39M | $3.79M | $3.80M | $373666.00 | $2.01M | $637639.00 | $580248.00 | $644168.00 | $742851.00 | $1.03M | $724778.00 | $704370.00 | $586581.00 | $7.42M | $2.91M |
| Long-term debt | $508000.00 | — | — | $1.93M | $100000.00 | — | — | — | — | — | — | — | — | — | $46282.00 | — | — | — | — | — |
| Shareholder equity | $4.41M | $4.29M | $7.44M | $3.99M | $-1.95M | $-2.73M | $-2.28M | $-921456.00 | $8.94M | $5.94M | $6.52M | $8.09M | $5.77M | $5.04M | $5.09M | $6.68M | $89.92M | $72.69M | $39.51M | $51.89M |
| Retained earnings | $-16.04M | $-19.66M | $-23.45M | $-29.49M | $-36.55M | $-37.95M | $-39.85M | $-41.45M | $-68.70M | $-79.55M | $-84.69M | $-89.14M | $-95.96M | $-100.03M | $-103.86M | $-107.41M | $-111.65M | $-115.96M | $-115.63M | $-84.97M |
| Accounts receivable | — | $231471.00 | $489620.00 | $216312.00 | $10435.00 | $2316.00 | $2581.00 | — | — | — | — | — | — | — | — | — | — | — | — | $3.70M |
| Inventory | — | $2.03M | $242901.00 | $117095.00 | $2528.00 | $18706.00 | $6846.00 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | $2.11M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |